C9h11fn2o5 uridine, II, -Doxy-II '-fluoro- (7ci, 8ci, 9CI, ACI)
Cas Subcriptio Number
784-71-4
H228
| Key physica proprietatibus | Valor | Conditio |
| Pondus | 246,19 | - |
| Melting Point (experimentalem) | 149-150 ° C | - |
| Density (praedicta) | 1.63 ± 0.1 G / CM3 | Temp: XX ° C; Press: DCCLX Torr |
| Pka (praedicta) | 9.39 ± 0.10 | Most Acidic Temp: XXV ° C |
Canonica ridet
O = C1C = CN (C (o) N1) C2OC (Co) C (O) C2F
Isomeric smiles
F [c @] I [C @@ h] (o [C @ h] (co), [@ h] 1o (= o) c2 =
INCHI
Inchi = 1s / c9h11fn2o5 / c10-6-7 (XV) IV (3-13) 17-8 (VI) 12-2-1-5 (XIV) 11,14,16) / T4- (H, 11,14,16) / T4-, 6-, 7-, 7- / M1 / S1, 7
Key Inchi
Uiywfozzekj, xvfcmesis, n
IV alia nomina huius substantiae
II, -Doxy-II, -fluorourgine (ACI); 1- (II, -Oxy-II-fluoro- β -d-ribofuranosyl) Uracil; II, -fluoro-II '-Doxyuridine; II, -fluoro, Uridine
Proprietatibus praesto
Optical et spargere
Scelerum
| Res | Valor | Conditio | Fons |
| Rotatory Powtical | LII deg | Solvente: aquam; Λ: 589.3 NM; Temp: XX ° C | (I) CAS |
(I) Codington, John F.; Journal de American Chemical Societate (MCMLXI), LXXXIII, 5030-1, Caplus
| Res | Valor | Source |
| Point liquescens | 149-150 ° C | (I) IC |
| Point liquescens | Vide plena Text | (II) CAS |
| Point liquescens | Vide plena Text | (III) IC |
(I) Mercer, John R.; Journal de medicinalibus Quaestiones (MCMLXXXIX), XXXII (VI), 1289-94, Caplus
(II) Codington, John F.; Journal de American Chemical Societate (MCMLXI), LXXXIII, 5030-1, Caplus
(III) De Aerschot, A.; Bulletin De Societes Chimiques Belges, (MCMLXXXIX), XCVIII (XII), 937-41, Caplus
Spectra praesto
I h NMR
XIII c NMR
Nmr hetero
IR
Missa
Raman
UV visibilis
Proprietatibus praesto
Biological
Proiectus
Densitas
Lipinski
Structuram related
| Res | Valor | Conditio | Fons |
| Bioconcentration factor | 1.0 | PH I; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH II; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH III; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH IV; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH V; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | Ph VI; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH VII; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH VIII; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH IX; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH X; Temp: XXV ° C | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
| Res | Valor | Conditio | Fons |
| Koc | 12,1 | PH I; Temp: XXV ° C | (I) ACD |
| Koc | 12,1 | PH II; Temp: XXV ° C | (I) ACD |
| Koc | 12,1 | PH III; Temp: XXV ° C | (I) ACD |
| Koc | 12,1 | PH IV; Temp: XXV ° C | (I) ACD |
| Koc | 12,1 | PH V; Temp: XXV ° C | (I) ACD |
| Koc | 12,1 | Ph VI; Temp: XXV ° C | (I) ACD |
| Koc | 12,1 | PH VII; Temp: XXV ° C | (I) ACD |
| Koc | 11,6 | PH VIII; Temp: XXV ° C | (I) ACD |
| Koc | 8,45 | PH IX; Temp: XXV ° C | (I) ACD |
| Koc | 2,33 | PH X; Temp: XXV ° C | (I) ACD |
| logd | -0.54 | PH I; Temp: XXV ° C | (I) ACD |
| logd | -0.54 | PH II; Temp: XXV ° C | (I) ACD |
| logd | -0.54 | PH III; Temp: XXV ° C | (I) ACD |
| logd | -0.54 | PH IV; Temp: XXV ° C | (I) ACD |
| logd | -0.54 | PH V; Temp: XXV ° C | (I) ACD |
| logd | -0.54 | Ph VI; Temp: XXV ° C | (I) ACD |
| logd | -0.54 | PH VII; Temp: XXV ° C | (I) ACD |
| logd | -0.56 | PH VIII; Temp: XXV ° C | (I) ACD |
| logd | -0.70 | PH IX; Temp: XXV ° C | (I) ACD |
| logd | -1.25 | PH X; Temp: XXV ° C | (I) ACD |
| Res | Valor | Conditio | Fons |
| logp | -0.538 ± 0.456 | Temp: XXV ° C | (I) ACD |
| Missam intrinsecam solubility | 4.9 g / l | Temp: XXV ° C | (I) ACD |
| Missam solubility | 4.9 g / l | PH I; Temp: XXV ° C | (I) ACD |
| Missam solubility | 4.9 g / l | PH II; Temp: XXV ° C | (I) ACD |
| Missam solubility | 4.9 g / l | PH III; Temp: XXV ° C | (I) ACD |
| Missam solubility | 4.9 g / l | PH IV; Temp: XXV ° C | (I) ACD |
| Missam solubility | 4.9 g / l | PH V; Temp: XXV ° C | (I) ACD |
| Missam solubility | 4.9 g / l | Ph VI; Temp: XXV ° C | (I) ACD |
| Missam solubility | 4.9 g / l | PH VII; Temp: XXV ° C | (I) ACD |
| Missam solubility | 5.2 g / l | PH VIII; Temp: XXV ° C | (I) ACD |
| Missam solubility | 6.9 g / l | PH IX; Temp: XXV ° C | (I) ACD |
| Missam solubility | XXV g / l | PH X; Temp: XXV ° C | (I) ACD |
| Missam solubility | 4.9 g / l | Unbuffered aqua PH 5.53; Temp: XXV ° C | (I) ACD |
| Molaris intrinsecam solubility | 0.020 Mol / l | Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.020 Mol / l | PH I; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.020 Mol / l | PH II; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.020 Mol / l | PH III; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.020 Mol / l | PH IV; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.020 Mol / l | PH V; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.020 Mol / l | Ph VI; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.020 Mol / l | PH VII; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.021 MOL / l | PH VIII; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.028 MOL / l | PH IX; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0,10 Mol / l | PH X; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 0.020 Mol / l | Unbuffered aqua PH 5.53; Temp: XXV ° C | (I) ACD |
| Pondus | 246,19 | ||
| PKA | 9.39 ± 0.10 | Most Acidic Temp: XXV ° C | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
| Res | Valor | Conditio | Fons |
| Densitas | 1.63 ± 0.1 G / CM3 | Temp: XX ° C; Press: DCCLX Torr | (I) ACD |
| Molaris volumine | 150.8 ± 5.0 CM3 / mol | Temp: XX ° C; Press: DCCLX Torr | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
| Res | Valor | Conditio | Fons |
| Sponte Rotatable vincula | 4 | (I) ACD | |
| H acceptors | 7 | (I) ACD | |
| H donos | 3 | (I) ACD | |
| H donator / Acceptor Sum | 10 | (I) ACD | |
| logp | -0.538 ± 0.456 | Temp: XXV ° C | (I) ACD |
| Pondus | 246,19 |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
| Res | Valor | Source |
| Polar superficies regio | 99.1 A2 | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
Spectra praesto
I h NMR
XIII c NMR
| Code aleam dicitur Source | |
| H228 flammabiles solidum | Europae chemical Agency (ECA) Classification & Labeling Inventory - Notified Classification et Labeling - Most Clementine_Vulgate Suspendisse, Europae Chemical Agency (ECA) Classification & Labeling Inventory - Notified Classification et Labeling - Most Suspendisse |
![C9h10n2o5 6h-Furo [II ', III, 4,5] Oxazolo [3,2-a] Pyrimidin-VI-unum, 2,3,3a, 2, 9a-TETRA-VI-Hydroxy-2- (Hydroxymethyl, III-Hydroxy-2R, 9a-TETRA-VI-Hydroxy-2R (Hydroxymethyl), Hydroxy-2R, 9a-TETRHA ydro-III-hydroxy-2r, 9a-TETRH-III-Hydroxy-2r, 9a-TETRH) - (2r, III R, 3as, 9ar) - (9c, 3as, 9ar) - (9c, 3s), 9AR) - (9c, 3as) - (9c, 3s), 9ar) - (9c, 3as)](https://cdn.globalso.com/nvchem/C9H10N2O5-6H-Furo-300x300.png)
![C17h19n3o6 thymidine, α -oxo- α - [(phenylmethyl) amino] - (aci)](https://cdn.globalso.com/nvchem/C17H19N3O6-Thymidine-300x300.png)
![C10H12N2O5 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrah ydro-3-hydroxy-2-(hydroxymethyl)-7-methyl-, (2R,3 R,3aS,9aR)- (9CI, ACI)](https://cdn.globalso.com/nvchem/C10H12N2O5-6H-Furo-300x300.jpg)